文献速递产科母胎医学

滋养层干细胞来源的异常甲基化在胎盘疾病发病与诊断中的作用

The role of aberrant methylation of trophoblastic stem cell origin in the pathogenesis and diagnosis of placental disorders.
PubMed 文献 · Prenat Diagn · 2017-01-24

研究检测正常早中晚孕期、子痫前期及葡萄胎孕妇胎盘血管化基因(VEGF、EGFR、c-jun)启动子DNA与组蛋白甲基化,发现早期妊娠高表达不依赖DNA甲基化而与H3K9/K27三甲基化相关,子痫前期中DNA与H3三甲基化均失调致VEGF、EGFR、c-jun低表达,VEGF启动子甲基化可能作为子痫前期和葡萄胎的胎儿DNA诊断标志物。

要点

  • 早期妊娠VEGF、EGFR、c-jun高表达不依赖DNA甲基化,与H3K9/K27三甲基化相关。
  • 子痫前期中DNA甲基化与H3三甲基化均失调,VEGF、EGFR、c-jun低表达。
  • 葡萄胎中c-jun异常高表达与其启动子H3K9me3水平降低相关。

核心结论

  • 胎盘疾病病理背后表观遗传现象失调很重要,启动子区DNA甲基化可作为这些病理妊娠的表观遗传标志物。

研究设计与样本

  • 研究分析正常早、中、晚孕期孕妇(每组n=30)及子痫前期(n=30)和葡萄胎(n=15)孕妇胎盘VEGF、EGFR、c-jun启动子的DNA和组蛋白甲基化,方法为甲基化敏感高分辨率熔解和染色质免疫沉淀 assay。

主要发现

  • 早期妊娠VEGF、EGFR、c-jun高表达不依赖DNA甲基化,而与H3K9/K27三甲基化相关。
  • 葡萄胎中c-jun异常高表达与其启动子H3K9me3水平降低相关。
  • 子痫前期条件下DNA甲基化和H3三甲基化均失调,随后VEGF、EGFR、c-jun低表达。
  • 启动子甲基化数据表明VEGF可能作为母体血浆中子痫前期和葡萄胎的新型胎儿DNA诊断标志物。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of the study is to investigate the role of methylation levels at promoter regions of placental vascularization genes (VEGF, EGFR, and c-jun) in pathogenesis and diagnosis of placental disorders. METHODS: We analyzed DNA and histone methylation at promoters of VEGF, EGFR, and c-jun via methylation-sensitive high-resolution melting and chromatin immunoprecipitation assay in pregnant women with normal pregnancy in first, second, and third trimesters (n = 30 in each group) and pregnant women with pregnancy complicated with preeclampsia (n = 30) and hydatidiform mole (n = 15). RESULTS: The higher expression of VEGF, EGFR, and c-jun in early pregnancy was observed to be independent of DNA methylation, while it was associated with H3 K9/K27 trimethylations. Also, abnormally higher expression of c-jun in GTDs was associated with lower H3K9me3 level at its promoter. Under preeclampsia conditions, we observed dysregulation of both DNA methylation and H3 trimethylation and subsequent low expression of VEGF, EGFR, and c-jun. Importantly, our promoter methylation data indicated that VEGF may act as novel fetal DNA diagnostic marker for preeclampsia and molar pregnancies in maternal plasma. CONCLUSION: These findings emphasize the importance of dysregulated epigenetic phenomenon behind the pathologies of placental disorders and use of promoter region DNA methylation as an epigenetic marker for these pathological pregnancies. © 2016 John Wiley & Sons, Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Rahat B, Najar RA, Hamid A, et al. The role of aberrant methylation of trophoblastic stem cell origin in the pathogenesis and diagnosis of placental disorders. Prenat Diagn. 2017. PMID: 27885689. doi:10.1002/pd.4974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。